None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy subjects aged 20 or older but younger than 40 years old.
Exclusion criteria
Exclusion criteria: -Pregnant women (Excluded if there is even the slightest suspicion of pregnancy based on questionnaire responses, including the last menstrual date). -Currently breastfeeding women. -Patients with such poor overall health that it is difficult to perform the examination. -Individuals with conditions such as claustrophobia or other seizures. -Patients with clear diagnoses of other causes of dementia or major neurological conditions, including traumatic brain injury, Parkinson's disease, Huntington's disease, motor neuron diseases, multiple sclerosis, etc. -Patients diagnosed with psychiatric disorders such as schizophrenia. -Patients with brain tumors, hydrocephalus, encephalitis, metabolic encephalopathies. -Women who are pregnant or using intrauterine contraceptive devices. -Individuals with cardiac pacemakers or metallic substances implanted inside the body (However, exclusion does not apply if the implanted/transplanted material is titanium or a titanium alloy or if a specialist has confirmed that there are no issues with a 3T MRI scan). -Patients with metallic substances in the brain area, such as brain vascular clips, orthodontic devices, that can cause distortion of the MRI image. -Individuals who have been exposed to radiation exceeding an effective dose of 50msV (5rem) in the past year. -Individuals who have undergone PET scans, coronary angiograms, abdomen-pelvic CT scans, or similar procedures more than twice in the past year. -Individuals working in jobs with significant radiation exposure. -Other individuals who are deemed inappropriate for participation by the clinical investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Formation of Florzolotau SUVR average maps for healthy subjects | — |
Secondary
| Measure | Time frame |
|---|---|
| Calculation of SUVR values in 6 regions associated with Braak stages | — |
Countries
Korea, Republic of
Contacts
Gachon University Gil Medical Center